Study of Safety and Pharmacokinetics of Oral Doses of EPX-100 in Healthy Subjects.
Status:
Completed
Trial end date:
2019-11-27
Target enrollment:
Participant gender:
Summary
This is a placebo-controlled, double-blind, 2-period study in 3 sequential groups of 8
healthy subjects each. The safety and pharmacokinetics of escalating single and multiple oral
doses of EPX-100 will be assessed in fasting healthy subjects and following a high-fat meal.